A systematic review of validated methods for identifying atrial fibrillation using administrative data

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue SUPPL. 1, 2012, Pages 141-147

  Jensen, Paul N ^a,b   Johnson, Karin ^c   Floyd, James ^a,b   Heckbert, Susan R ^a,b,c   Carnahan, Ryan ^d   Dublin, Sascha ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c GROUP HEALTH RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Atrial fibrillation; Cardiac arrhythmia; Epidemiology; Positive predictive value; Sensitivity; Validation

Indexed keywords

ABSTRACT REPORT; ALGORITHM; ARTICLE; ELECTROCARDIOGRAM; ELECTRONIC MEDICAL RECORD; HEALTH CARE MANAGEMENT; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HOSPITAL PATIENT; HUMAN; MEDICAL RECORD REVIEW; OUTPATIENT; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; VALIDATION STUDY; VALIDITY;

ALGORITHMS; ATRIAL FIBRILLATION; DATABASES, FACTUAL; ELECTRONIC HEALTH RECORDS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; VALIDATION STUDIES AS TOPIC;

EID: 84856066615     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2317     Document Type: Article

References (24)

1. Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82: 2N-9N.
2. Naccarelli GV, Varker H, Lin J, et al. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 2009; 104: 1534-1539. DOI:S0002-9149(09)01388-5 [pii]10.1016/j.amjcard.2009.07.022.
3. Food and Drug Administration. Listing of DMEs is adapted from "Safety Reporting Requirements for Human Drug and Biological Products; Proposed Rule". Department of Health and Human Services, Washington, DCMarch 14, 2003. [3 December 2010].
4. The Observational Medical Outcomes Partnership (OMOP). Health Outcomes of Interest. Foundation for the National Institutes of Health, Bethesda [7 June 2010].
5. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20: 37-46.
6. Alonso A, Agarwal SK, Soliman EZ, et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2009; 158: 111-117. DOI:S0002-8703(09)00362-7 [pii]10.1016/j.ahj.2009.05.010.
7. Antani MR, Beyth RJ, Covinsky KE, et al. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation. J Gen Intern Med 1996; 11: 713-720.
8. Brass LM, Krumholz HM, Scinto JM, et al. Warfarin use among patients with atrial fibrillation. Stroke 1997; 28: 2382-2389.
9. Flaker GC, McGowan DJ, Boechler M, et al. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. Am Heart J 1999; 137: 307-312.
10. Hravnak M, Hoffman LA, Saul MI, et al. Atrial fibrillation: prevalence after minimally invasive direct and standard coronary artery bypass. Ann Thorac Surg 2001; 71: 1491-1495.
11. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455-2461.
12. Shen AY, Yao JF, Brar SS, et al. Racial/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation. Stroke 2008; 39: 2736-2743.
13. Shireman TI, Howard PA, Kresowik TF, et al. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke 2004; 35: 2362-2367.
14. Whittle J, Wickenheiser L, Venditti LN. Is warfarin underused in the treatment of elderly persons with atrial fibrillation? Arch Intern Med 1997; 157: 441-445.
15. Yuan Z, Bowlin S, Einstadter D, et al. Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries. Am J Public Health 1998; 88: 395-400.
16. Borzecki AM, Wong AT, Hickey EC, et al. Identifying hypertension-related comorbidities from administrative data: what's the optimal approach? Am J Med Qual 2004; 19: 201-206.
17. Go AS, Hylek EM, Phillips KA, et al. Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2000; 102: 11-13.
18. Brophy MT, Snyder KE, Gaehde S, et al. Anticoagulant use for atrial fibrillation in the elderly. J Am Geriatr Soc 2004; 52: 1151-1156.
19. Dublin S, French B, Glazer NL, et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med 2006; 166: 2322-2328.
20. Glazer NL, Dublin S, Smith NL, et al. Newly detected atrial fibrillation and compliance with antithrombotic guidelines. Arch Intern Med 2007; 167: 246-252.
21. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375.
22. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-354. DOI:114/7/e257 [pii]10.1161/CIRCULATIONAHA.106.177292.
23. Gage BF, Boechler M, Doggette AL, et al. Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. Stroke 2000; 31: 822-827.
24. Go AS, Hylek EM, Borowsky LH, et al. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med 1999; 131: 927-934.